A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG).
about
Revisiting the role of cladribine in acute myeloid leukemia: an improvement on past accomplishments or more old news?Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML).Vosaroxin in relapsed/refractory acute myeloid leukemia: efficacy and safety in the context of the current treatment landscape.Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.Comparison of clinical remission and survival between CLAG and FLAG induction chemotherapy in patients with refractory or relapsed acute myeloid leukemia: a prospective cohort study.Comparison of cladribine- and fludarabine-based induction chemotherapy in relapsed or refractory acute myeloid leukaemia.A new intensive conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with refractory or relapsed acute myeloid leukemia.
P2860
Q26860830-A4097552-79CF-4FB6-81E0-B57DF5AD89FCQ35546759-A07DEA5B-7ED4-49E9-947F-10A2F95210B1Q39071892-15F29A0B-3392-42C7-9865-BE7D9C24D4F0Q39296422-844AFFA5-F166-4C81-8718-24CBD6DB331AQ39342733-B7DE1BE7-39AD-4453-9520-D1C76CA7C829Q41607636-B387917B-6D2F-4440-92B8-FBCE979B4675Q48225965-8AB7342D-BC82-4038-8FC7-5F00162D81F0Q51563126-07E2BAB1-BAF9-45CC-B40B-992D145212ADQ55380860-049D0294-B2C1-43E3-8FCB-F5FCC3583D98
P2860
A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG).
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A multicenter, open, non-compa ...... h Adult Leukemia Group (PALG).
@en
A multicenter, open, non-compa ...... h Adult Leukemia Group (PALG).
@nl
type
label
A multicenter, open, non-compa ...... h Adult Leukemia Group (PALG).
@en
A multicenter, open, non-compa ...... h Adult Leukemia Group (PALG).
@nl
prefLabel
A multicenter, open, non-compa ...... h Adult Leukemia Group (PALG).
@en
A multicenter, open, non-compa ...... h Adult Leukemia Group (PALG).
@nl
P2093
P2860
P1476
A multicenter, open, non-compa ...... h Adult Leukemia Group (PALG).
@en
P2093
A Dmoszyńska
A Hellmann
A Skotnicki
A Wierzbowska
A Wrzesień-Kuś
E Lech-Marańda
J Hołowiecki
K Kuliczkowski
Polish Adult Leukemia Group
P2860
P304
P356
10.1034/J.1600-0609.2003.00122.X
P577
2003-09-01T00:00:00Z